NCT07098403View on ClinicalTrials.gov

A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma

PHASE3RecruitingINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

September 3, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

June 30, 2028

Conditions
Asthma
Interventions
DRUG

SHR-1905 Injection

SHR-1905 injection.

DRUG

SHR-1905 Placebo Injection

SHR-1905 placebo Injection.

Trial Locations (1)

510830

RECRUITING

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY